Almitas Capital LLC An2 Therapeutics, Inc. Transaction History
Almitas Capital LLC
- $205 Million
- Q4 2024
A detailed history of Almitas Capital LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 1,313,111 shares of ANTX stock, worth $1.54 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
1,313,111Holding current value
$1.54 Million% of portfolio
0.87%Shares
1 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.8MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$6.73 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.21 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny580KShares$678,3340.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$677,2250.79% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny528KShares$618,1110.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $22.7M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...